SCLERO.ORG
Search
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Autoimmune
Media Stories
Scleroderma
ISN/Website
Scleroderma Archive
2015: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2017 - 2016 - 2015 - 2014

April 2015 Scleroderma News

Investigational Scleroderma Drug Takes Novel Approach To Treating Inflammation. A new proposed treatment for scleroderma, Resunab, will soon be in Phase 2 clinical trials. Scleroderma News, 03/16/2015. (Also see Scleroderma Clinical Trials: Resunab)

New Study Summarizes Scientific Findings Concerning Scleroderma Renal Crisis (SRC). SRC is still affecting a meaningful population of patients with systemic sclerosis, so a vigilant diagnosis and therapy is needed to prevent adverse outcomes and enhance survival. Seminars in Arthritis and Rheumatism, 02/27/2015. (Also see Scleroderma Renal Crisis)

Researchers Report Audiovestibular Dysfunction in Systemic Sclerosis Patients. There is an association between systemic sclerosis and inner ear function resulting in audiovestibular abnormalities. The Egyptian Rheumatologist, 02/26/2015. (Also see Autoimmune Ear Diseases)

A preliminary study of acoustic radiation force impulse (ARFI) quantification for the assessment of skin in diffuse cutaneous systemic sclerosis (dSSc). ARFI quantification is feasible and reliable for assessing the skin involvement in dcSSc and may be a valuable adjunct to skin evaluation in patients with SSc. PubMed, J Rheumatol, 2015 Mar;42(3):449-55. (Also see Skin Fibrosis)

Decreased numbers of endothelial progenitor cells (EPCs) in patients in the early stages of systemic sclerosis (SSc). Decreased EPCs in SSc patients might be an important therapeutic target for the prevention of vascular complications. PubMed, Microvasc Res, 2015 Jan 13;98C:82-87. (Also see Vascular Involvement in Systemic Scleroderma)

A reactive oxygen species(ROS)-mediated loop maintains the increased expression of NOX2 and NOX4 in skin fibroblasts from patients with systemic sclerosis (SSc). NOX2 and NOX4 generate ROS in SSc fibroblasts and play a critical role in cell activation and DNA damage. PubMed, Arthritis Rheumatol, 02/23/2015. (Also see Causes of Scleroderma: Fibroblasts)

Early systemic sclerosis-opportunities for treatment. The early diagnosis of SSc, before the development of fibrosis in internal organs, will allow the introduction of immunosuppressive medications in these patients in a controlled setting. PubMed, Clin Rheumatol, 02/26/2015. (Also see Common Medical Tests for Scleroderma)

Interstitial Lung Disease in Scleroderma. The diagnosis of interstitial lung disease hinges on careful clinical evaluation and pulmonary function tests and high-resolution computed tomography. Rheumatic Disease Clinics of North America, 03/05/2015. (Also see Pulmonary Fibrosis Diagnosis)

Go to Scleroderma Medical News: March 2015
 
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including memorials for
Frances Maude Baldwin Watson, Rubye Mai Blocker Westmoreland.
Thanks to Tamika Forteau and Paul and Margaret Phifer for raising scleroderma awareness!
Donate or Shop Now
 

TOLL FREE HOTLINE, U.S. and Canada: 1-800-564-7099
Ask for our Free Info Packet by email or postal mail!

SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected] to request our Welcome email, or to report bad links or to update this page content. Privacy Policy.
 

The most important thing in the world to know about scleroderma is sclero.org!

Donate Now
Copyright 1998-2017, International Scleroderma Network. AKA Scleroderma from A to Z and SCLERO.ORG. All Rights Reserved.